Vestibular Schwannoma and Neurofibromatosis Education Day Part 2: NF2 in the Young Patient
17th February, 2024, 08:35 - 09:35
Imperial Ballroom
This session reviews current practices in NF2 in this special patient population, controversial situations, active clinical trials, and genetics.
Objectives
At the conclusion of this session, attendees will be able to:
- Understand genetic variations of NF2 disease and their clinical impact.
- Outline overall treatment strategy and medical and surgical options in young NF2 patients.
- Delineate nuances in decision-making in young patients with aggressive NF2 phenotype.
Current Schedule
As a faculty member of this session, you can click on names to email the speaker. Phone numbers are below names
| Speaker | Title | Role | Times |
|---|---|---|---|
| Kaleb Yohay 212-263-7744 |
Moderator | - | |
| Daniel Lee 6178752898 |
Moderator | - | |
| Omar Pathmanaban +441612068340 |
Strategy and Goals of Care for the Young Patient with NF2 Genetic Severity Profile | Speaker | 8:35 am - 8:50 am |
| Kaleb Yohay 212-263-7744 |
Active Clinical Trials and Medical Management Considerations | Speaker | 8:50 am - 9:05 am |
| Lisa Schimmenti 507-284-3215 |
Genetic Variation in NF2 and Implications in Management for the Pediatric Population | Speaker | 9:05 am - 9:20 am |
| J. Thomas Roland, Jr. (212) 263-5565 |
Management of Small, Growing Vestibular Schwannomas in the Young NF2 Patient | Speaker | 9:20 am - 9:35 am |